Cite
Idelalisib inhibits osteoclast differentiation and pre-osteoclast migration by blocking the PI3Kδ-Akt-c-Fos/NFATc1 signaling cascade.
MLA
Yeon, Jeong-Tae, et al. “Idelalisib Inhibits Osteoclast Differentiation and Pre-Osteoclast Migration by Blocking the PI3Kδ-Akt-c-Fos/NFATc1 Signaling Cascade.” Archives of Pharmacal Research, vol. 42, no. 8, Aug. 2019, pp. 712–21. EBSCOhost, https://doi.org/10.1007/s12272-019-01163-8.
APA
Yeon, J.-T., Kim, K.-J., Son, Y.-J., Park, S.-J., & Kim, S. H. (2019). Idelalisib inhibits osteoclast differentiation and pre-osteoclast migration by blocking the PI3Kδ-Akt-c-Fos/NFATc1 signaling cascade. Archives of Pharmacal Research, 42(8), 712–721. https://doi.org/10.1007/s12272-019-01163-8
Chicago
Yeon, Jeong-Tae, Kwang-Jin Kim, Young-Jin Son, Sang-Joon Park, and Seong Hwan Kim. 2019. “Idelalisib Inhibits Osteoclast Differentiation and Pre-Osteoclast Migration by Blocking the PI3Kδ-Akt-c-Fos/NFATc1 Signaling Cascade.” Archives of Pharmacal Research 42 (8): 712–21. doi:10.1007/s12272-019-01163-8.